LeMaitre to Present at the 25th Annual Needham Virtual Healthcare Conference
Rhea-AI Summary
LeMaitre Vascular (Nasdaq:LMAT) said management will present at the 25th Annual Needham Virtual Healthcare Conference on Thursday, April 16, 2025 at 2:15 PM EDT.
The virtual presentation provides a scheduled, public management update to investors and analysts; no financial results or additional agenda details were disclosed.
Positive
- None.
Negative
- None.
News Market Reaction – LMAT
In the Apr 7 session, LMAT gained 1.07%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 27 | Investor conferences | Neutral | -4.8% | Announced participation in five investor conferences scheduled for March 2026. |
| Feb 25 | Q4 2025 earnings | Positive | +24.4% | Reported Q4 2025 sales growth, margin expansion, higher EPS, and raised FY2026 guidance. |
| Feb 11 | Earnings date notice | Neutral | -0.2% | Announced timing and webcast details for Q4 2025 earnings release and call. |
| Nov 12 | Investor conferences | Neutral | -0.4% | Outlined participation in three healthcare conferences in late 2025. |
| Nov 06 | Q3 2025 earnings | Positive | +1.4% | Delivered Q3 2025 growth, margin gains, dividend declaration, and raised full‑year guidance. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Earnings releases have previously coincided with positive price reactions, while conference participation updates have seen flat to negative moves.
Over the past six months, LeMaitre has combined solid financial execution with active investor outreach. Q3 and Q4 2025 earnings (news IDs 931846 and 1018597) featured double‑digit sales growth, margin expansion, higher EPS, and increased capital return authorizations, and both drew positive price reactions. In contrast, multiple conference-participation announcements (e.g., news IDs 935016 and 1020266) produced flat to negative moves. Today’s Needham presentation fits the ongoing pattern of frequent conference visibility alongside strong reported fundamentals.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BURLINGTON, Mass., April 07, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will present at the 25th Annual Needham Virtual Healthcare Conference on Thursday, April 16, 2025, at 2:15 PM EDT.
About LeMaitre
LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

Contact: Sandra Millar LeMaitre Vascular, Inc. +1-781-425-1686 smillar@lemaitre.com